The Molecular Chaperone αB-crystallin Enhances Amyloid β Neurotoxicity
- 1 August 1999
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 262 (1), 152-156
- https://doi.org/10.1006/bbrc.1999.1167
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tauNature Neuroscience, 1998
- The alternative conformations of amyloidogenic proteins and their multi-step assembly pathwaysCurrent Opinion in Structural Biology, 1998
- Alzheimer's Disease--Genotypes, Phenotype, and TreatmentsScience, 1997
- Selective Inhibition of Aβ Fibril FormationJournal of Biological Chemistry, 1996
- Reduced Chaperone-like Activity of αAins-crystallin, an Alternative Splicing Product Containing a Large Insert PeptidePublished by Elsevier BV ,1995
- Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.Proceedings of the National Academy of Sciences, 1994
- αB crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's diseaseJournal of the Neurological Sciences, 1993
- Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly stateJournal of Neuroscience, 1993
- Alpha-crystallin can function as a molecular chaperone.Proceedings of the National Academy of Sciences, 1992
- Expression and aggregation of recombinant αA-crystallin and its two domainsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1992